Loss of BRCA1 leads to an increased sensitivity to Bisphenol A

Calafat, 2005, Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population, Environ. Health Perspect., 113, 391, 10.1289/ehp.7534 Calafat, 2008, Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004, Environ. Health Perspect., 116, 39, 10.1289/ehp.10753 Fan, 1999, BRCA1 inhibition of estrogen receptor signaling in transfected cells, Science, 284, 1354, 10.1126/science.284.5418.1354 Fan, 2001, Role of direct interaction in BRCA1 inhibition of estrogen receptor activity, Oncogene, 20, 77, 10.1038/sj.onc.1204073 Friedman, 1994, The search for BRCA1, Cancer Res., 54, 6374 Harkin, 1999, Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1, Cell, 97, 575, 10.1016/S0092-8674(00)80769-2 Hess-Wilson, 2006, Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis, Breast Cancer Res. Treat., 96, 279, 10.1007/s10549-005-9082-y Jones, 2008, Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer, Oncogene, 27, 794, 10.1038/sj.onc.1210674 Keri, 2007, An evaluation of evidence for the carcinogenic activity of bisphenol A, Reprod. Toxicol., 24, 240, 10.1016/j.reprotox.2007.06.008 Krishnan, 1993, Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving, Endocrinology, 132, 2279, 10.1210/en.132.6.2279 Markey, 2002, Endocrine disruptors: from wingspread to environmental developmental biology, J. Steroid Biochem. Mol. Biol., 83, 235, 10.1016/S0960-0760(02)00272-8 Narod, 2004, BRCA1 and BRCA2: 1994 and beyond, Nat. Rev. Cancer, 4, 665, 10.1038/nrc1431 Olea, 1996, Estrogenicity of resin-based composites and sealants used in dentistry, Environ. Health Perspect., 104, 298, 10.1289/ehp.96104298 Olsen, 2003, Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4′-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7, Pharmacol. Toxicol., 92, 180, 10.1034/j.1600-0773.2003.920408.x Rosen, 2005, BRCA1 in hormonal carcinogenesis: basic and clinical research, Endocr. Relat. Cancer, 12, 533, 10.1677/erc.1.00972 Schafer, 1999, Estrogenicity of bisphenol A and bisphenol A dimethacrylate in vitro, J. Biomed. Mater. Res., 45, 192, 10.1002/(SICI)1097-4636(19990605)45:3<192::AID-JBM5>3.0.CO;2-A Somasundaram, 1997, Arrest of the cell cycle by the tumor-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1, Nature, 389, 187, 10.1038/38291 Soto, 1995, The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants, Environ. Health Perspect., 103, 113, 10.1289/ehp.95103s7113 Soto, 2008, Neoplasia as development gone awry: the role of endocrine disruptors, Int. J. Androl., 31, 288, 10.1111/j.1365-2605.2007.00834.x Tsutsumi, 2005, Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction, J. Steroid Biochem. Mol. Biol., 93, 325, 10.1016/j.jsbmb.2004.12.008 Vandenberg, 2009, Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption, Endocr. Rev., 30, 75, 10.1210/er.2008-0021 vom Saal, 2007, Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure, Reprod. Toxicol., 24, 131, 10.1016/j.reprotox.2007.07.005 Villalobos, 1995, The E-screen assay: a comparison of different MCF7 cell stocks, Environ. Health Perspect., 103, 844, 10.1289/ehp.95103844 Wagner, 1997, Cre-mediated gene deletion in the mammary gland, Nucleic Acids Res., 25, 4323, 10.1093/nar/25.21.4323 Welshons, 2006, Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure, Endocrinology, 147, S56, 10.1210/en.2005-1159 Wetherill, 2002, The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells, Mol. Cancer Ther., 1, 515 Xu, 1999, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, Nat. Genet., 22, 37, 10.1038/8743 Yamada, 2002, Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester, Reprod. Toxicol., 16, 735, 10.1016/S0890-6238(02)00051-5 Zheng, 2001, BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor, Proc. Natl. Acad. Sci. U.S.A., 98, 9587, 10.1073/pnas.171174298